{"title":"Modulation of Epidermal Growth Factor Stimulated ERK Phosphorylation and Cell Motility by Inositol Trisphosphate Kinase.","authors":"M C Sekar, K Shahiwala, L Leloup, A Wells","doi":"10.1166/jpsp.2014.1010","DOIUrl":null,"url":null,"abstract":"<p><p>Epidermal growth factor [EGF] mediated stimulation of its receptor in endothelial cell [EC] is accompanied by phosphorylation of the EGF-receptor [EGFR] and activation of phospholipase C-<i>γ</i>, resulting in the breakdown of phosphatidylinositol(4,5)-bisphosphate and generating inositol (1,4,5)-trisphosphate [IP<sub>3</sub>] and diacylglycerol. IP<sub>3</sub> thus formed can be further converted to inositol (1,3,4,5)-tetrakisphosphate [IP<sub>4</sub>] by an enzyme called IP<sub>3</sub>-kinase [IP<sub>3</sub>K]. In this study we have investigated the effect of modulation of intracellular IP<sub>3</sub>K activity by the use of an inhibitor, 2-trifluoromethyl [6-(4-nitrobenzyl)-purine] [IP<sub>3</sub>KI] and siRNA against IP<sub>3</sub>KB on EGF-induced ERK-phosphorylation and cell motility. EGF stimulated ERK-phosphorylation that has been implicated in EGF-stimulated cell migration was inhibited by both IP<sub>3</sub>KI and siRNA against IP<sub>3</sub>KB. Inhibition of ERK-phosphorylation was accompanied by decreased cell migration in the presence of IP<sub>3</sub>KI.</p>","PeriodicalId":90906,"journal":{"name":"Journal of pharmaceutical sciences and pharmacology","volume":"1 2","pages":"160-164"},"PeriodicalIF":0.0000,"publicationDate":"2014-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1166/jpsp.2014.1010","citationCount":"9","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of pharmaceutical sciences and pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1166/jpsp.2014.1010","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 9
Abstract
Epidermal growth factor [EGF] mediated stimulation of its receptor in endothelial cell [EC] is accompanied by phosphorylation of the EGF-receptor [EGFR] and activation of phospholipase C-γ, resulting in the breakdown of phosphatidylinositol(4,5)-bisphosphate and generating inositol (1,4,5)-trisphosphate [IP3] and diacylglycerol. IP3 thus formed can be further converted to inositol (1,3,4,5)-tetrakisphosphate [IP4] by an enzyme called IP3-kinase [IP3K]. In this study we have investigated the effect of modulation of intracellular IP3K activity by the use of an inhibitor, 2-trifluoromethyl [6-(4-nitrobenzyl)-purine] [IP3KI] and siRNA against IP3KB on EGF-induced ERK-phosphorylation and cell motility. EGF stimulated ERK-phosphorylation that has been implicated in EGF-stimulated cell migration was inhibited by both IP3KI and siRNA against IP3KB. Inhibition of ERK-phosphorylation was accompanied by decreased cell migration in the presence of IP3KI.